Evidence map›Paper›PMID 42618586›Full record

Observational studyScientific reports2026

Diagnostic value of [

Alina Toni Küper, Ieva Ciuciulkaite, Anja Welt, Sofia Carrilho Vaz, Ilektra Antonia Mavroeidi, Rainer Hamacher, Tristan Demmert, Kim Magaly Pabst, Alexandros Moraitis, Loic Djaileb and 7 more

Registry-linked trialAbstract readComparative StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04571086 (68-Ga-FAPI-PET for Tumor Detection), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04571086 recruitingnot on this map

68-Ga-FAPI-PET for Tumor Detection: A Prospective Observational Trial

Typeobservational_patient_registrySponsorUniversity Hospital, EssenRan2020 to 2027Enrolled500ConditionsMalignant Neoplasm
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Alina Toni KüperDepartment of Nuclear Medicine and German Cancer Consortium (DKTK), University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, Essen, 45147, Germany. Alina.Kueper@uk-essen.de.ORCID 0009-0009-4380-1629
Ieva CiuciulkaiteDepartment of Nuclear Medicine and German Cancer Consortium (DKTK), University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, Essen, 45147, Germany.
Anja WeltDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Sofia Carrilho VazDepartment of Nuclear Medicine and Radiopharmacology, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
Ilektra Antonia MavroeidiDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Rainer HamacherDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Tristan DemmertDepartment of Nuclear Medicine and German Cancer Consortium (DKTK), University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, Essen, 45147, Germany.
Kim Magaly PabstDepartment of Nuclear Medicine and German Cancer Consortium (DKTK), University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, Essen, 45147, Germany.
Alexandros MoraitisDepartment of Nuclear Medicine and German Cancer Consortium (DKTK), University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, Essen, 45147, Germany.
Loic DjailebNuclear Medicine Department, LRB, CHU Grenoble Alpes, INSERM, Université Grenoble Alpes, Grenoble, France.
Robert SeifertDepartment of Nuclear Medicine and German Cancer Consortium (DKTK), University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, Essen, 45147, Germany.
Lale UmutluInstitute of Interventional and Diagnostic Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Martin SchulerDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Ken HerrmannDepartment of Nuclear Medicine and German Cancer Consortium (DKTK), University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, Essen, 45147, Germany.
Wolfgang Peter FendlerDepartment of Nuclear Medicine and German Cancer Consortium (DKTK), University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, Essen, 45147, Germany.
Sherko KümmelBreast Unit Essen, Kliniken Essen-Mitte, Essen, Germany.
David KerstingDepartment of Nuclear Medicine and German Cancer Consortium (DKTK), University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, Essen, 45147, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This single-center subgroup analysis of a prospective trial (NCT04571086) at University Hospital Essen investigated tumor uptake and detection rates of [

Indexed as

Fluorodeoxyglucose F18Gallium RadioisotopesPositron-Emission TomographyRadiopharmaceuticalsTriple Negative Breast NeoplasmsAdultAgedFemaleHumansMiddle AgedNeoplasm StagingProspective StudiesQuinolinesTheranostic Nanomedicine68Ga-FAPIFluorodeoxyglucose F18Gallium RadioisotopesQuinolinesRadiopharmaceuticalsFAPIMolecular imagingPETTheranosticsTriple-negative breast cancer

Identifiers

PMID42618586
PMCPMC13490564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.